promote allergic medicine with Kyorin Holdings unit
July 11 (Reuters) - Kaken Pharmaceutical Co Ltd 4521.T :
* Says the company entered into basic agreement with Kyorin
Holdings Inc 4569.T 's unit on co-promotion of an allergic
medicine, whose exclusive sales right is owned by the Kyorin
Holdings's unit
Source text in Japanese:https://goo.gl/Kk9DGV;
https://goo.gl/uUL4RP
Further company coverage: 4521.T 4569.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))